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The objective of this study was to evaluate the efficacy of an Asthma Nurse Practice (ANP) in primary health care. 
A 1Zmonth (September 1994August 1995) open, prospective intervention study with pre- and post-test 
comparisons was performed on patients with asthma treated at a primary care centre in Sweden. 
Sixty-three patients with mild or moderate asthma participated and medication, structured follow-up and 
education in self-management at an ANP were assessed over a 1Zmonth period. 
The main outcome measures assessed were pulmonary function, eosinophil cationic protein (ECP) in serum, 
respiratory symptoms, patient knowledge of asthma and emergency visits. 
ANP in primary health care increased patient knowledge of asthma and medication. The number of patients with 
nocturnal symptoms decreased significantly. Pulmonary function was improved: vital capacity (VC) 98-106, forced 
expiratory volume in 1 set (FEVi) 93-100 and peak expiratory flow (PEF) 98-115% of predicted (P<O*OOl). 
Variation in PEF fell from 21 to 12% (P<O*OOl). ECP was significantly reduced. Visits to the emergency room 
were 60% fewer during the year of intervention (P~0.01). 
In conclusion, patients attending an Asthma Nurse Practice, comprising a structured programme for asthma 
management, improve their knowledge and asthma control. 
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Introduction 
The prevalence of asthma has increased during the past 
decades (l-3). The prevalence in Sweden ranges between 5 
and So?, the highest figures being found in northern 
Sweden, probably due to climatic conditions (4-6). 
The major problem with management of asthma today is 
not lack of effective and safe medication. Early intervention 
with inhaled steroids in a low or moderate dose will result 
in adequate asthma control in most patients. However, 
despite effective medication many asthmatics are under 
treated for a number of reasons, with a negative impact on 
their quality of life. Poor compliance to prescribed 
medication, poor perception of symptoms and lack of 
knowledge or instruction of how to act in case of asthma 
deterioration are probably the most important factors 
behind the high asthma morbidity in the community. 
These factors have all attracted attention in the interna- 
tional and national consensus documents (7-8) of asthma 
treatment published recently. However, patient education 
and introduction of self-management plans are time- 
consuming and hard to adopt in common practice. One 
way to facilitate implementation of guidelines is to build a 
team around the patient with a registered nurse (RN) 
Paper received 1 October 1998 and accepted 4 May 1999. 
Correspondence should be addressed to: M. Lindberg, Department 
of Research and Development in Primary Health Care, S-595 30 
Mjiilby, Sweden. Fax: + 46-142-78096. 
0954-6111/99/080584+05 $12.00/O 
taking care of substantial part of the education and self- 
management programme. 
During the last few years asthma practices led by nurses 
have been introduced into primary health care in Sweden. 
The objective of the nursing-led practices is to increase 
patient knowledge about asthma and its treatment, as 
proposed in the international consensus report on asthma 
(7). The aims are to encourage patients to observe their 
symptoms, record the effect of the treatment and take 
responsibility for their medication. In this way, the patients 
themselves take control of their disease. 
At a primary health care unit, with a patient base of 
6200, an Asthma Nurse Practice (ANP) was started in 1994 
in order to implement the international guidelines for 
asthma management. It was led by a RN, who had been 
specially trained in care of patients with asthma, and was 
supervized by the local general practitioner (GP). 
The aim of the present study was to evaluate the impact 
of asthma guidelines in primary health care and whether the 
ANP contributed to an improvement in asthma outcome as 
regards: pulmonary function and symptoms; eosinophil 
cationic protein (ECP) as a marker of inflammatory activity 
in the airways; emergency visits; and patient knowledge of 
asthma and its treatment. 
Subjects 
All patients with respiratory problems who were 
referred to or consulted the ANP during 1 year (September 
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TABLE 1. Demographic data for patients (n= 63) with 
asthma at a primary health care centre participating in the 
study 
Sex (n) 
Female 
Male 
Age, (years) 
<20 
2&39 
40-59 
160 
Duration of asthma, (years) 
< 10 
lo-19 
20-29 
30-39 
40-59 
Allergic rhinitis (current or past history) (n) 
Family history (n) 
Asthma 
Allergy 
Smoking habits (n) 
Current smoker 
Ex-smoker 
Never smoked 
40 
23 
9 
28 
17 
9 
36 
18 
5 
3 
1 
44 
41 
34 
11 
10 
42 
1994August 1995) were included in the study (n= 83). 
Twelve patients were excluded as the diagnosis of asthma 
could not be confirmed. Seven had moved from the study 
area and one subject was referred to a pediatrician. The 
remaining 63 patients had a diagnosis of asthma according 
to the American Thoracic Society Criteria (9). Fifty-one 
subjects were diagnosed before their first visit to the ANP. 
The remaining 12 had no previous diagnosis of asthma. 
Demographic data are shown in Table 1. 
Methods 
During the year of study, all patients made at least three 
visits to the ANP: at entry (visit l), after 4 weeks (visit 2) 
and after 1 year (visit 3). Additional follow-up visits (to the 
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ANP and GP) were decided individually according to status 
and requirement of the patient. No patient entered the 
study who was in need of emergency treatment or required 
medical intervention at visit 1. Six months after study entry, 
a follow-up visit was made at the GP office. 
The first visit was scheduled for 90 min. Visits 2 and 3 
took approximately lh. Patients continued on their 
previous medication between visits 1 and 2. 
The objective of the ANP was to care for each patient 
according to his/her own level of knowledge about their 
disease and medication, thus the ANP presented individua- 
lized education. Adjustment of medication in collaboration 
with the GP and monitoring of symptoms, peak expiratory 
flow (PEF) diaries and lung function were also included in 
the management plan. Telephone contacts for follow-up 
discussions were used occasionally. At every visit to the 
ANP, it was emphasized that patients should feel that they 
were given the time they needed without any stress (10) and 
that the patients should feel confident in the RN. The 
purpose was to create a trusting professional relationship 
between the RN and the patients, making them feel 
involved in the diagnostic and therapeutic procedures. 
The objective was an open communication between the RN 
and the patients to encourage them to make their own 
informed treatment choices and feel confident in their self- 
managed programme (11,12). 
Table 2 shows the assessments performed at the pre- 
scheduled study visits. 
Pulmonary function was measured by a dry spirometer 
(Flowscreen Jaeger, Wurzburg, Germany). The best result 
of three attempts was recorded. Reversibility was tested 15 
min after inhalation of either terbutaline Turbuhaler 
(Draco Lakemedel A.B., Lund, Sweden) 0.5-2.0 mg or 
salbutamol diskhaler (Glaxo Welcome A.B., Hiilndal, 
Sweden) 0.4-1.2 mg. Each patient was given the same dose 
at visits 1 and 3. Short acting b-agonists were withheld for 
at least 4 h before testing. 
PEF diaries were used throughout the study as a part 
of the self-management plan. Morning and evening PEF 
were recorded (best of three attempts) at the patient’s 
own discretion and as mandatory before visits 2 and 3. 
Variation in PEF was calculated over the last 1Cday period 
before visits 2 and 3, using the following formula: 
PEF,, - PEF,&PEF,, x 100. The highest and lowest 
TABLE 2. Assessments performed at the pre-scheduled study visits 
Visit 1 Visit 2 Visit 3 
Questionnaire (Table 5) X X 
Spirometry (VC, FEVr, PEF) X X 
Reversibility test X X 
ECP X X 
Education and control of inhalation technique X X X 
Adjustment of medication X X 
Control of patient diary X X 
Vc,vital capacity; FEVr, forced expiratory volume in 1 set; PEF, peak expiratory 
flow. 
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TABLE 3. Pulmonary function and ECP at start and end of study 
Start of study End of study P-value 
Spirometry (n = 63) 
VC% pred 
FEVl% pred 
PEF% pred 
PEF diary (n = 62) 
Variation (%) 
ECP (n = 63) 
clg-’ 
98 (5G143) 106 (73-154) <O*OOl 
93 (52-128) 100 (60-178) <O.OOl 
98 (48-l 58) 115 (59-175) <O.OOl 
21 (649) 12 (2-30) <O.OOl 
16 (4-73) 11 (2-39) <O*Ol 
Reference material spirometry; Children; Zepleta; Adults; European Convention 
for Constructional Steelwork (ECCS). Reference value: 80-120%. 
Data are given as mean (range). 
PEF values during the 16day period were used in the normally distributed variables. P-values of less than 0.05 
analysis. were considered significant. 
STATISTICAL ANALYSIS 
Results 
Analysis were performed as pre-post measures (at visit 1 
and after 1 year at visit 3) of the different variables for each 
individual. Only changes in a positive direction were of 
interest. Therefore, only one-tailed P-values have been 
calculated. McNemar’s test was used for variables with only 
two levels, and a t-test was used for approximately 
All patients completed the study. During the study year, the 
average number of visits to the ANP per patient was 3.7, 
including study visits 1-3. Lung function improved 
significantly (Table 3). Reversibility to P-agonists decreased 
from 10 to 2% (P-cO.05). Variation in PEF was reduced 
from 21 to 12% (P-eO.001). Forty-three subjects had a PEF 
variation > 15% at visit 1 compared to 15 patients 1 year 
TABLE 4. Response figures to patient questionnaires (n = 63) at study entry (questionnaire 1) and after 1 year (questionnaire 
2). Response alternatives ‘yes’ or ‘no’. Number of ‘yes’ answers only are presented 
Questionnaire 1 Questionnaire 2 P-value 
Do you feel that you have good knowledge 
of your asthma medicine? 
Do you feel that you have good knowledge 
of your asthma disease? 
Does it matter in which order one takes 
ones asthma medicine? 
Are you worried that your asthma medicine 
could give you side-effects in the future? 
Do you have access to any instrument to measure 
your lung function with? 
Do you exercise regularly? 
Have you learnt anything new about asthma 
during the last 12 months from the staff at 
the primary health care? 
Are you bothered by coughing during 
nights? 
Are you bothered by coughing in the 
daytime? 
Do you suffer from choking during nights? 
Do you suffer from choking in the daytime? 
35 56 
23 60 
28 
17 
37 61 P<O.OOl 
42 43 ns 
7 48 P<O*OOl 
18 
14 
9 
5 
54 
17 
8 
13 
3 
2 
P<O*OOl 
P<O.OOl 
P<O~OOl 
ns 
P<O*Ol 
n.s 
P<O.O5 
n.s 
n.s. = not significant. 
later. ECP fell significantly (Table 3). Nineteen patients had 
an ECP value > 15 pg 1-l (upper normal limit) at visit 1. 
Eleven patients still exceeded that value after 1 year. 
All patients answered the questionnaire at visits 1 and 3. 
Nocturnal symptoms and patient knowledge about asthma 
and medication improved significantly (Table 4). No 
significant changes were seen in the patients’ global 
assessment of daytime symptoms, exercise habits and 
worries about medication (Table 4). 
The average number of emergency visits per patient were 
0.5 during the pre-study year, which diminished to O-2 
during the study (PC O-01). Absence from school or work 
due to asthma fell from an average of 1.3 days in the year 
before intervention to 1-O during the year of study (not 
significant). 
Eleven patients were smokers when the study started and 
three of them gave up smoking during the study year. 
The average daily dose of inhaled steroids at study entry 
was 729 ug (n=38). After 1 year, the number of patients 
who inhaled steroids had increased to 49 using an average 
dose of 604 pg day- ‘. Medication details as study and after 
1 year of follow-up are given in Table 5. 
All patients in the study expressed a positive reaction to 
their visits to the ANP. 
Discussion 
The study shows that an Asthma Practice in primary health 
care, based on the international consensus document on 
asthma management (7), has a positive effect on asthma 
morbidity and disease control. The resources put into the 
ANP, with a RN using approximately 3-4 per patient per 
year, seem reasonable in relation to the obtained result. 
A structured follow-up programme and patient educa- 
tion are considered fundamental for the successful outcome 
of self-managed care in asthma (10,13). Treatment of 
asthma must be tailored to each patient’s need, as practised 
in this study (13,14). To achieve proper asthma control it is 
necessary to stress the importance of regular anti-inflam- 
matory medication, appearance of break-through symp- 
toms, decline in lung function and how to act in case of 
deterioration (15). This is partly a pedagogic commission, 
which may be undertaken by specially trained nurses. This 
issue has also been addressed in previous studies (13,16,17). 
Our study shows that an ANP can complement traditional 
care, in accordance with the intention of current guidelines, 
to give patients with asthma an improved general well- 
being as an overall goal in asthma therapy. Furthermore, 
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an ANP will save the GP’s time and should be regarded as a 
part of an ‘asthma-team’, with the focus on the patient. 
Earlier studies in this field have identified the need to 
improve nurse awareness and use of consensus guidelines 
(18). Guidelines can also be used to modify the behaviour 
of health professionals (19). 
The problem of compliance is well recognized in patients 
with chronic diseases (11,20). To educate the patient to 
become a ‘decision maker’ and to help him/her to make an 
informed choice in concordance with health professionals is 
beneficial in allowing the patient to take responsibility for 
his/her disease (12,21). 
The methods used to evaluate asthma care in this study 
included both objective and subjective assessments. No 
previous study has evaluated the care of asthmatic patients 
by nurses as comprehensively. It could be argued that we 
used no control group, but as all the patients who entered 
the study were referred to the ANP because of respiratory 
discomfort it was deemed unethical to allow patients to 
continue on their previous regimen for a whole year. In a 
way, the patients were their own controls as the status of 
their asthma at the time of entry into the study reflected the 
usual standard of asthma care at that particular centre. 
Patients were entered during a relatively stable phase of 
their asthma, therefore regression towards the mean, as an 
explanation of the results obtained, seems unlikely. The 
magnitude of improvement seen in this study can only be 
explained by better overall asthma care, including, adjust- 
ment of medication. 
The compliance to prescribed medication was not 
followed in our study, but the favourable outcome of the 
intervention suggests a better compliance and a possible 
improvement in inhaler technique. 
Daytime asthma was, surprisingly, not improved but the 
way in which the questions were formulated may have been 
too crude to distinguish a difference in daytime symptom 
severity. Patient worries about possible future side-effects of 
their medication did not change during the study. Their 
propensity to exercise regularly was not affected; it seems 
that influencing changes in patients’ life-style is difficult, 
even though the RN stressed the importance of physical 
exercise in the consultations. 
Although no health economic analysis was performed in 
this study, it is our firm belief that the ANP represents a 
resource-effective way to reduce the costs of asthma care in 
the community. 
In conclusion, the implementation of international 
guidelines for asthma management in primary health care 
TABLE 5. Asthma medication at visit 1 and after 1 year. The number of patients on each class of drug are given 
Medication 
(n = 63) 
Short-acting Long-acting 
inhaled 82 inhaled /3* 
agonist agonist 
Inhaled 
corticosteroid 
Inhaled Inhaled Oral 
ipratropium sodiumcromoglycate bronchodilators 
Visit 1 58 5 38 1 2 8 
After 1 year 63 9 49 4 2 5 
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by initiating an Asthma Nurse Practice improves patient 
knowledge and all parameters of asthma control. 
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